# OnCo record nct06252649 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06252649/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06252649", "NCT06252649" ;
  schema:name "Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal"@en ;
  schema:alternateName "CodeBreaK 301"@en ;
  schema:description "A phase 3 trial of Sotorasib, Panitumumab in colorectal cancer, run by Amgen, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06252649/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06252649> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-07-17" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/kras-g12c-colorectal/> ;
  onco:technologies <https://onco.cc/technologies/kras-inhibitors/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/sotorasib/>, <https://onco.cc/drugs/panitumumab/> ;
  onco:companies <https://onco.cc/companies/amgen/> ;
  onco:trials <https://onco.cc/trials/codebreak-300/> .